PROJECT 3: Respiratory syncytial virus (RSV) is the leading cause of respiratory failure in young children and severe RSV bronchiolitis has been identified as risk factor for the subsequent development of asthma in children. Currently, there is no effective vaccine for RSV and pharmacologic treatment is far from optimal. Development of new therapeutic agents is critical to reduce the morbidity and mortality from this important pathogen, and to perhaps modify the risk of childhood asthma. Our preliminary data suggest that prostaglandin (PG) 12 is a novel therapeutic target for RSV. In a well characterized murine model of RSV infection, we reported that transgenic mice that constitutively overexpress PGI synthase (PGIS) were significantly protected from RSV-induced illness. In addition, we found that mice which cannot signal through the PGI2 receptor (IP) had significantly exacerbated weight loss and delayed recovery after RSV infection. Further, in a collaborative study of infants admitted with RSV bronchiolitis, we found that a functional polymorphism in the promoter region of the PGI synthase (PGIS) gene was associated with an increase in the urinary PGI2 metabolite and less severe bronchiolitis. These data strongly suggest that PGI2 and IP signaling protect against RSV-induced disease. The long term objective of this application are to define role of PGI2 in RSV-induced airway pathophysiology and the mechanism by which PGI2 protects against RSV-induced illness. We have isolated an RSV strain (01/2-20) from an infant with bronchiolitis that induced airway responsiveness, airway mucus expression, and high levels of lung IL-13 protein in mice.
In aim 1, we hypothesize that PGI2 and IP signaling protects against RSV 01/2-20 -induced airway responsiveness, inflammation, and pathology. We also have preliminary data which reveals that PGI2 selectively downregulates bone marrow derived dendritic cell and macrophage expression of TLR4, a pattern recognition receptor that is activated by the RSV F protein.
In aim 2 we hypothesize that PGI2 modulates RSV-induced immunopathology in a TLR4-dependent manner. The proposed studies may result in a novel, effective therapy for RSV bronchiolitis.

Public Health Relevance

RSV is the leading cause of bronchiolitis and causes >100,000 infant hopsitalizations in the US each year. Studies have also revealed that severe RSV infection in infancy is associated with the later development of childhood asthma. This application will examine the role of PGI2 in RSV-induced airway disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI095227-01
Application #
8196529
Study Section
Special Emphasis Panel (ZAI1-PA-I (M1))
Project Start
2011-08-01
Project End
2016-07-31
Budget Start
2011-08-01
Budget End
2012-07-31
Support Year
1
Fiscal Year
2011
Total Cost
$254,482
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Turi, Kedir N; Romick-Rosendale, Lindsey; Ryckman, Kelli K et al. (2017) A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma. J Allergy Clin Immunol :
Rajan, Devi; Chinnadurai, Raghavan; Keefe, Evan O et al. (2017) Protective role of Indoleamine 2,3 dioxygenase in Respiratory Syncytial Virus associated immune response in airway epithelial cells. Virology 512:144-150
Cephus, Jacqueline-Yvonne; Stier, Matthew T; Fuseini, Hubaida et al. (2017) Testosterone Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation. Cell Rep 21:2487-2499
Stier, Matthew T; Goleniewska, Kasia; Cephus, Jacqueline Y et al. (2017) STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral Infection. J Immunol 199:510-519
Johnston, Henry Richard; Hu, Yi-Juan; Gao, Jingjing et al. (2017) Identifying tagging SNPs for African specific genetic variation from the African Diaspora Genome. Sci Rep 7:46398
Rosas-Salazar, Christian; Hartert, Tina V (2017) Prenatal exposures and the development of childhood wheezing illnesses. Curr Opin Allergy Clin Immunol 17:110-115
Chatterjee, Srirupa; Luthra, Priya; Esaulova, Ekaterina et al. (2017) Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses. Nat Microbiol 2:17101
Boyoglu-Barnum, S; Todd, S O; Meng, J et al. (2017) Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective. J Virol 91:
Zhou, Weisong; Zhang, Jian; Goleniewska, Kasia et al. (2016) Prostaglandin I2 Suppresses Proinflammatory Chemokine Expression, CD4 T Cell Activation, and STAT6-Independent Allergic Lung Inflammation. J Immunol 197:1577-86
Bloodworth, Melissa H; Newcomb, Dawn C; Dulek, Daniel E et al. (2016) STAT6 Signaling Attenuates Interleukin-17-Producing ?? T Cells during Acute Klebsiella pneumoniae Infection. Infect Immun 84:1548-55

Showing the most recent 10 out of 89 publications